Parents
Sign in to add mentor| Maryse Lapeyre-Mestre | grad student | 2010 | Toulouse 3 | |
| (Nouvelles méthodes de mesure du risque médicamenteux en pharmacovigilance) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bouzid W, Tavassoli N, Berbon C, et al. (2023) Exploring Population Characteristics and Recruitment Challenges in Older People Experiencing Falls at Home without Hospitalization or with an Emergency Department Visit: Insights from the RISING-DOM Experience. Clinical Interventions in Aging. 18: 1995-2008 |
| Bouzid W, Tavassoli N, Berbon C, et al. (2022) Impact of a personalised care plan for the elderly calling emergency medical services after a fall at home: The RISING-DOM multi-centre randomised controlled trial protocol. Bmc Geriatrics. 22: 182 |
| Chebane L, Tavassoli N, Bagheri H, et al. (2010) [Not Available]. Therapie. 65: 447-58 |
| Chebane L, Tavassoli N, Bagheri H, et al. (2010) [Drug-induced hyperglycemia: a study in the French pharmacovigilance database]. Therapie. 65: 447-58 |
| Tavassoli N, Voisin S, Carrie D, et al. (2010) High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 10: 29-35 |
| Tavassoli N, Lapeyre-Mestre M, Sommet A, et al. (2009) Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). British Journal of Clinical Pharmacology. 68: 422-6 |
| Tavassoli N, Montastruc JL. (2009) Is there any relationship between actual benefit and added value of drugs and pharmacovigilance alerts? British Journal of Clinical Pharmacology. 68: 124-5 |
| Tavassoli N, Montastruc-Fournier J, Montastruc JL, et al. (2008) Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses. British Journal of Clinical Pharmacology. 66: 566-7 |
| Tavassoli N, Sommet A, Lapeyre-Mestre M, et al. (2007) Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Safety. 30: 1063-71 |
| Tavassoli N, Duchayne E, Sadaba B, et al. (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. European Journal of Clinical Pharmacology. 63: 221-8 |